The biotech Merus received the first-ever FDA accelerated approval for a systemic treatment targeting a specific genetic ...

Wisconsin border in 'America's Dairyland,' Eli Lilly is staking one of its largest-ever manufacturing bets to continue its ...

The cold-blooded shooting death of UnitedHealthcare CEO Brian Thompson on Wednesday sent shockwaves through corporate America ...

The US Patent and Trademark Office has withdrawn its controversial proposal for a new rule that would make it easier to ...

The cold-blooded shooting death of UnitedHealthcare CEO Brian Thompson on Wednesday sent shockwaves through corporate America ...

Amgen is investing $1 billion for a second factory in North Carolina after already allocating more than half a billion ...

Protara Therapeutics' experimental cell therapy TARA-002 showed promising results in bladder cancer patients, with 13 of 18 ...

National Resilience replaces CEO Rahul Singhvi with COO William Marth. Moderna opens mRNA facility in Australia. Reckitt ...

Merck’s top medical exec said its recent bet on a VEGF bispecific antibody — one of the hottest areas in R&D — is not a form ...

Genmab is licensing a second investigational anti-glycan monoclonal antibody from Scancell as part of an agreement inked ...

CG Oncology says its immunotherapy candidate that could help patients avoid surgery may deliver lasting responses in a ...

GSK's BD team was busy leading up to the Thanksgiving holiday. In the last two days, the UK-based pharma has announced three ...